This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page | Sign In | Register
News & Press: Dental News

Direct Oral Anticoagulants

jeudi 6 juin 2019   (1 Comments)
Posted by: Paola Pino
Share |

Continuation of direct oral anticoagulants in oral surgery – a literature review

Implant placement and augmentation procedures are associated with the risk of haemorrhaging, particularly in patients on anti-coagulants. A recent literature review from the Medical University of Graz has summarised strategies for treating patients who are receiving direct oral anticoagulants (DOACs).

A systematic search of high-yield journals and the electronic database ‘PubMed’ was carried out by the researchers. Search terms included ‘DOAC’, ‘oral surgery’ and ‘implant surgery’ to find a broad spectrum of perioperative haemostatic strategies.

Five studies were identified as being relevant. Two of the studies compared continuation of DOAC with discontinuation. Three of the studies found no significance for bleeding events in patients on DOACs, when compared to procedures involving patients not on anticoagulants.

Based on the studies reviewed, the authors found that simple implant placements do not increase risk of haemorrhaging, and so continuation of DOACs is advisable. For more complex cases, suspending the use of DOACs may help limit the risk of complications. The author’s note that further studies are required to better determine the factors associated with haemorrhaging and to find the best strategy to reduce bleeding.

This study was presented as an e-poster at the 2018 EAO Congress.

 

Comments...

Tooraj Moravej says...
Posted mercredi 19 juin 2019
if the patients INR below 3.8 , there is no need of discontinueing the DOACs , this is a protocol we are following with out facing any problem

Our Mission
As one of the leading associations within the field of implant dentistry in the world, the EAO aims to improve the quality of patient care by bridging the gap between science and clinical practice.
EAO Office
38 rue Croix des Petits Champs, 75001 Paris, France
+33 (0)1 42 36 62 20
info@eao.org
Stay Connected
Find A Dentist